Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Haemonetics Corp.
Nieuws
Haemonetics Corp.
HAE
NYS
: HAE
| ISIN: US4050241003
2/06/2023
88,13 USD
(+1,80%)
(+1,80%)
2/06/2023
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
11 mei 2023 ·
Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
· Persbericht
25 april 2023 ·
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023
· Persbericht
20 april 2023 ·
Haemonetics Publishes Inaugural Corporate Responsibility Report
· Persbericht
2 maart 2023 ·
Haemonetics Introduces Next Generation "Intelligent Control" Software for Cell Saver® Elite®+ Autotransfusion System
· Persbericht
27 februari 2023 ·
Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference
· Persbericht
7 februari 2023 ·
Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
· Persbericht
6 januari 2023 ·
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023
· Persbericht
19 december 2022 ·
Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference
· Persbericht
7 november 2022 ·
Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
· Persbericht
6 oktober 2022 ·
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022
· Persbericht
4 oktober 2022 ·
Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center
· Persbericht
12 september 2022 ·
Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio
· Persbericht
29 augustus 2022 ·
Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals
· Persbericht
24 augustus 2022 ·
Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
· Persbericht
10 augustus 2022 ·
Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
· Persbericht
7 juli 2022 ·
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2023 Results: August 10, 2022
· Persbericht
24 juni 2022 ·
Haemonetics Completes Move to New Manufacturing Facility in Clinton, PA
· Persbericht
6 juni 2022 ·
Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022
· Persbericht
10 mei 2022 ·
Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
· Persbericht
10 mei 2022 ·
Haemonetics to Host Investor Day Event on June 29, 2022
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe